Search

everythinglearnresearchcommunity

for

Search:↓

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

A new tool simplifies alopecia areata severity scoring but needs validation.

Venusia CeraPlus cream and lotion effectively reduce eczema severity and improve skin moisture.

Alopecia areata treatments often don't lead to lasting improvement.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Topical flutamide works as well as hydroquinone for melasma but needs more safety checks.

Tph cells are linked to the severity of systemic lupus erythematosus.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Vitamin D analogues can significantly help hair regrowth in Alopecia Areata patients.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Umbilical cord masks can help reduce melasma in postpartum women.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Rituximab may cause skin issues, but baricitinib can help improve them.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Alefacept does not effectively treat severe alopecia areata.